Home / HealthNews


EU renews approval for herbicide glyphosate for five years

BRUSSELS (Reuters) – The European Commission said on Tuesday it had renewed for five years the license for the weed-killer glyphosate, a key ingredient in Monsanto Co’s top-selling Roundup, following a heated debate over whether it causes cancer. FILE PHOTO: Monsanto’s Roundup weedkiller atomizers are displayed for sale at a …

Read More »

Cholera resurges in Zambian capital Lusaka, WHO says

GENEVA (Reuters) – Cholera has killed 15 people and made 547 sick in Zambia’s capital Lusaka and the rising caseload is expected to grow further as the rainy season starts, according to the World Health Organization. The outbreak began on Sept. 28 but appeared to die down by Oct 20, …

Read More »

U.S. FDA accepts application for Indivior’s new schizophrenia drug

(Reuters) – U.S. Food and Drug Administration (FDA) accepted Indivior’s application for its new schizophrenia treatment, the British drugmaker said on Tuesday, boosting hopes of marketing the drug in the country. The London-listed company, which specializes in heroin addiction treatment, said the FDA had accepted its application for RBP-7000, an …

Read More »

Air pollution fine particles linked to poor sperm quality

(Reuters Health) – Exposure to fine particles in air pollution may be another factor that affects men’s sperm quality and their fertility, suggest researchers in Taiwan. Although the clinical effect may be small, the findings could be important from a public health perspective due to worldwide exposure to pollution, the …

Read More »

Roche: Tecentriq cocktail slows kidney cancer progression

ZURICH (Reuters) – Combining Roche’s Tecentriq immunotherapy with its older drug Avastin reduced the risk of disease worsening or death (PFS) for the initial treatment of advanced kidney cancer in some patients, the Swiss drugmaker said on Monday FILE PHOTO: The logo of Swiss pharmaceutical company Roche is seen outside …

Read More »